Vintafolide

All ESMO 2014 abstracts with reference to vintafolide are listed below

• LBA40_PR - TARGET: A randomized, phase II trial comparing vintafolide versus vintafolide plus docetaxel, versus docetaxel alone in second-line treatment of folate-receptor-positive non-small cell lung cancer (NSCLC) patients
• 894P - PRECEDENT subset analysis: safety and disease control with vintafolide monotherapy following discontinuation of pegylated liposomal doxorubicin (PLD)
• 1171P - Real-time identification of lung adenocarcinoma tumor lesions likely to respond to vintafolide treatment by using etarfolatide